REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 220 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,129 | -13.7% | 534,322 | +90.3% | 0.00% | 0.0% |
| Q2 2023 | $7,106 | -20.6% | 280,758 | +1.0% | 0.00% | 0.0% |
| Q1 2023 | $8,953 | +57.2% | 277,935 | -9.9% | 0.00% | +33.3% |
| Q4 2022 | $5,696 | -99.8% | 308,564 | +228.5% | 0.00% | 0.0% |
| Q3 2022 | $2,537,000 | +305.9% | 93,930 | +107.8% | 0.00% | – |
| Q2 2022 | $625,000 | +57.0% | 45,206 | +121.4% | 0.00% | – |
| Q1 2022 | $398,000 | -88.8% | 20,416 | -90.6% | 0.00% | -100.0% |
| Q4 2021 | $3,556,000 | +203.4% | 217,870 | +417.7% | 0.00% | 0.0% |
| Q3 2021 | $1,172,000 | +44.9% | 42,084 | +54.2% | 0.00% | – |
| Q2 2021 | $809,000 | -52.1% | 27,298 | -54.8% | 0.00% | -100.0% |
| Q1 2021 | $1,688,000 | +109.7% | 60,399 | +112.5% | 0.00% | – |
| Q4 2020 | $805,000 | -6.3% | 28,417 | -16.8% | 0.00% | -100.0% |
| Q3 2020 | $859,000 | -3.0% | 34,162 | -5.8% | 0.00% | 0.0% |
| Q2 2020 | $886,000 | +169.3% | 36,270 | +63.3% | 0.00% | – |
| Q1 2020 | $329,000 | -63.3% | 22,210 | -59.8% | 0.00% | – |
| Q4 2019 | $896,000 | +90.2% | 55,227 | +52.2% | 0.00% | – |
| Q3 2019 | $471,000 | -12.5% | 36,283 | -12.6% | 0.00% | – |
| Q2 2019 | $538,000 | +1.7% | 41,503 | +24.0% | 0.00% | – |
| Q1 2019 | $529,000 | +62.3% | 33,477 | +106.4% | 0.00% | – |
| Q4 2018 | $326,000 | -52.2% | 16,217 | -40.8% | 0.00% | – |
| Q3 2018 | $682,000 | +100.0% | 27,398 | +120.8% | 0.00% | – |
| Q2 2018 | $341,000 | -57.4% | 12,410 | -52.2% | 0.00% | -100.0% |
| Q1 2018 | $800,000 | +17.0% | 25,950 | +35.6% | 0.00% | 0.0% |
| Q4 2017 | $684,000 | +112.4% | 19,136 | +63.3% | 0.00% | – |
| Q3 2017 | $322,000 | +9.5% | 11,719 | +4.9% | 0.00% | – |
| Q2 2017 | $294,000 | -29.3% | 11,172 | -44.2% | 0.00% | – |
| Q1 2017 | $416,000 | +147.6% | 20,012 | +147.6% | 0.00% | – |
| Q4 2016 | $168,000 | +2700.0% | 8,082 | +1925.6% | 0.00% | – |
| Q3 2016 | $6,000 | -87.2% | 399 | -88.4% | 0.00% | – |
| Q2 2016 | $47,000 | +1466.7% | 3,440 | +1865.7% | 0.00% | – |
| Q1 2016 | $3,000 | -80.0% | 175 | -61.4% | 0.00% | – |
| Q4 2015 | $15,000 | -98.5% | 453 | -98.7% | 0.00% | -100.0% |
| Q3 2015 | $1,016,000 | +8366.7% | 35,022 | +9116.3% | 0.00% | – |
| Q2 2015 | $12,000 | -86.4% | 380 | -91.3% | 0.00% | – |
| Q1 2015 | $88,000 | +1000.0% | 4,387 | +793.5% | 0.00% | – |
| Q4 2014 | $8,000 | +300.0% | 491 | +342.3% | 0.00% | – |
| Q3 2014 | $2,000 | -97.0% | 111 | -94.4% | 0.00% | – |
| Q2 2014 | $67,000 | +1016.7% | 1,979 | +952.7% | 0.00% | – |
| Q1 2014 | $6,000 | – | 188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |